European Breast Cancer Conference (EBCC-15)

Thank you for being part of #EBCC15. Over the past days, clinicians, researchers and patient advocates came together to exchange knowledge and advance multidisciplinary breast cancer care. Thank you to all speakers, participants and partners. #BreastCancer #Oncology @OncoAlert

📢 EBCC 15 final session: Manifesto Removing age-related barriers to improve equity in breast cancer care Experts discussed how to ensure that age does not limit access to high-quality breast cancer care across Europe. #BreastCancer #Oncology @OncoAlert

🤝 #EBCC15 We are grateful for the continued support of our sponsors. Their commitment plays a key role in making EBCC-15 a hub for collaboration and scientific progress in breast cancer research. Thank you! #BreastCancer #Oncology @OncoAlert

⚖️ Debate at #EBCC15 Take part in this lively debate between high-level participants on: Is intensive follow-up with brain MRI needed in high-risk HER2-positive early breast cancer? #BreastCancer #Oncology @OncoAlert

⚖️ Debate ongoing at #EBCC15 Take part in this lively debate between high-level participants on: Precision margin assessment in breast cancer surgery: the antidote to overtreatment? #BreastCancer #Oncology @OncoAlert

News from #EBCC15: Tumour DNA circulating in patients’ blood after pre-surgery treatments predicts whether breast cancer will return ow.ly/9Tax50YzyBn

News from #EBCC15: Early results from a trial of active surveillance for low-risk DCIS are ‘reassuring’ ow.ly/CL3Q50Yzy8M

🌅 Final day is here at #EBCC15 Join us for a last day of sessions, discussions and key insights as the conference comes to a close! #BreastCancer #Oncology @OncoAlert

🚨 Starting soon at #EBCC15 The Natera Industry Forum begins in 15 minutes in the Spotlight Area. #BreastCancer #Oncology @OncoAlert

🚨 Starting soon at #EBCC15 Menarini Stemline Satellite Symposium📍 Room 111 Strategic treatment sequencing and novel approaches in 2L+ ER+/HER2- mBC #BreastCancer #Oncology @OncoAlert

🤝 Thank you to our sponsors and exhibitors at #EBCC15 Your support helps make this conference possible and contributes to advancing breast cancer research and care. #BreastCancer #Oncology @OncoAlert

News from #EBCC15: Radiotherapy rather than surgery may help reduce risk of lymphoedema in patients with breast cancer: results from pilot study - EBCC 15 @OncoAlert ow.ly/jnxw50Yz1Ch

News from #EBCC15: Elinzanetant reduces severity and frequency of hot flushes and night sweats, regardless of type of hormone treatment breast cancer patients receive ow.ly/SFl050Yz1iv

🌅 Good morning from #EBCC15 Another full day of sessions ahead, with new insights, perspectives and conversations shaping breast cancer care. Let’s dive in! #BreastCancer #Oncology @OncoAlert

#EBCC15 Morning Barcelona

🤝 #EBCC15 We are proud to count on the support of our sponsors! Their contribution helps maintain EBCC-15 as a leading platform for innovation and scientific exchange in breast cancer research. Thank you! #BreastCancer #Research #Oncology @OncoAlert

⚖️ Debate ongoing at #EBCC15 Take part in this lively debate between high-level participants on: Trastuzumab Deruxtecan in ER+ metastatic breast cancer after 1-2 lines of endocrine therapy. #BreastCancer #Oncology @OncoAlert

⚖️ Debate at #EBCC15 Take part in this lively debate between high-level participants on: AI in mammography screening programs: Replacing human readings. #BreastCancer #AI #Imaging #Oncology @OncoAlert